Gilead Seeks Cancer Drug Deals to Bolster 79% Share Rise

David Paul Morris/Bloomberg

A scientist at Gilead Sciences Inc., analyzes patient antibody levels at the Gilead Sciences Inc. laboratory in Foster City, California.